After closing a $3.6 million Series A round of financing just last month, MacuLogix has raised $2 million of a planned $5 million in Series B funding for commercial activities in 2014 and 2015. The Hummelstown, PA-based company develops tools for diagnosing age-related macular degeneration. The company’s current investors, which include Berwind Private Equity, Roche Venture Fund, Life Sciences Greenhouse of Central Pennsylvania and Ben Franklin Technology Partners, have all committed to participate in the Series B round.
